Skip to main content
SpringerLink
Log in
Book cover

The Physiology and Pathophysiology of Exercise Tolerance pp 281–286Cite as

Effects of Drugs on Exercise Tolerance in Patients with Cardiovascular Disease

  • Chapter

  • 246 Accesses

Abstract

A consequence of most cardiovascular diseases is exercise limitation. The main causes of exercise intolerance are angina pectoris due to myocardial ischemia, dyspnea in congestive heart failure due to loss of muscle mass, and muscular dysfunction or valvular disease. Besides the heart, peripheral arterial occlusive disease is a major cause for exercise intolerance. Possibilities for drug therapy are limited in this disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrams J. Nitrate tolerance and dependence. Am. Heart J. 99: 113–123, 1980.

    Article  PubMed  CAS  Google Scholar 

  2. Badger F., G. Brown, C.A. Gallery, E.L Bolson, and H.T. Dodge. Coronary artery dilatation and hemody-namic responses after isosorbide dinitrate therapy in patients with coronary artery disease. Am. J. Cardiol. 56:390–395, 1985.

    Article  PubMed  CAS  Google Scholar 

  3. Bassenge E., and A. Mulsch. Anti-ischemic actions of molsidomine by venous and large coronary dilatation on combination with antiplatelet effects. J. Cardiovasc. Pharmacol. 14:23–28, 1989.

    Google Scholar 

  4. Brown B.G., E.L. Bolson, R.B. Peterson, CD. Pierce, and H.T. Dodge. The mechanisms of nitroglycerin action: Stenosis vasodilation as a major component of drug response. Circulation 65: 1089–1097, 1981.

    Article  Google Scholar 

  5. Brown B.G. Response of normal and diseased epicardial coronary arteries to vasoactive drugs: Quantitative angiographic studies. Am. J. Cardiol. 56: 23E–29E, 1985.

    Article  PubMed  CAS  Google Scholar 

  6. Brown E.J., P.H. Chew, A. MacLean, K. Gelperin, J.P. Ilgenfritz, and M. Blumenthal. Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Amer.J.Cardiol. 75: 596–600, 1995.

    Article  PubMed  Google Scholar 

  7. Bussmann W.-D., and K. Wienhöfer. Akut-und Langzeiteffekte von 100 mg N-Methyldopamin (Ibopamin) bei Patienten mit chronischer Herzinsuffizienz Stadium II-III NYHA. Herz/Kreislauf 27:135–138, 1995.

    Google Scholar 

  8. Lieverse A.G., DJ. vanVeldhuisen, A.J. Smit, J.G. Zijlstra, S. Maeijer, W.D. Reitsma, K.I. Lie, and A.R.J. Girbes. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure. J. Cardiovasc.Pharmacol. 25:361–367, 1995.

    Article  PubMed  CAS  Google Scholar 

  9. Littler W.A., and D.J. Sheridan. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. Brit.Heart J. 73:428–433, 1995.

    Article  PubMed  CAS  Google Scholar 

  10. Macgowan G.A., D. O’Callaghan, H. Webb, and J.H. Horgan. The effects of captopril on training in patients with ischemic heart disease. Clin. Cardiol. 15:330–334, 1992.

    Article  PubMed  CAS  Google Scholar 

  11. McLenachan J.M., J.T. Wilson, and H.J. Dargie. Importance of acillary properties of beta-blockers in angina: A study of celiprolol and atenolol. Br. Heart J. 59:685–689, 1988.

    Article  PubMed  CAS  Google Scholar 

  12. Nechwatal W., M. Stauch, H. Sigel, P. Kress, F. Bitter, H. Geffers, and W.E. Actam. Effects of Molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris. Clin. Cardiol. 4: 248–253, 1981.

    PubMed  CAS  Google Scholar 

  13. Nechwatal W., E. König, J. Isbary, H. Greding, and M. Stauch. Haemodynamic and electrocardiographic effects of frusemide during supine exercise in patients with angina pectoris. Br. Heart J. 44: 67–74, 1980.

    Article  PubMed  CAS  Google Scholar 

  14. Nechwatal W., A. Stange, H. Sigel, P. Kress, A. Resch, and M. Stauch. Der Einfluß von Piretanid auf die zentrale Hämodynamik und Belastungstoleranz von Patienten mit Angina pectoris. Herz/Kreisl. 14: 91–96, 1982.

    Google Scholar 

  15. Needleman P., S. Lang, and E.M. Johnson. Organic nitrates: Relationship between biotransformation and rational angina pectoris therapy. J. Pharmacol. Exp. Ther. 181: 489–497, 1972.

    PubMed  CAS  Google Scholar 

  16. Olsen S.L., E.M. Gilbert, D.G. Renlund, D.O. Taylor, F.D. Yanowitz, and M.R. Bristow. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study. JACC 25:1225–31, 1995.

    PubMed  CAS  Google Scholar 

  17. Parker J.O., B. Farrell, K.A. Lahey, and J. Moe. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N. Engl. J. Med. 316:1440–1444, 1987.

    Article  PubMed  CAS  Google Scholar 

  18. Panvilov V., I. Wahlqvist, and G. Osson. Use of beta-adrenoceptor blockers in patients with congestive heart failure. Cardiovasc. Drugs Therap. 9:273–287, 1995.

    Article  Google Scholar 

  19. Pouleur, H. Neurohormonal and hemodynamic effects of ibopamine. Clin. Cardiol. 18:1-17-1-21, 1995.

    Google Scholar 

  20. Stauch M, Grewe N, and Nissen H. Die Wirkung von 2-und 5-Isosorbidmononitrat auf das Belastungs-EKG von Patienten mit Koronarinsuffizienz. Verh. Dtsch. Ges. Kreislaufforsch. 41, 182–184, 1975

    PubMed  CAS  Google Scholar 

  21. Stauch M, and N. Grewe. Die Wirkung von Isosorbiddinitrat, Isosorbid-2-und 5-Mononitrat auf das Belastungs-EKG und auf die Hämodynamik während Vorhofstimulation bei Patienten mit Angina pectoris. Z Kardiol. 68:687, 1979.

    PubMed  CAS  Google Scholar 

  22. Stauch, M., G. Grossmann, A. Schmidt, P. Richter, J. Waitzinger, D. Wanjura, W.E. Actam, and W. König. Effect of gallopamil on left ventricular function in regions with and without ischaemia. Europ. Heart J. 8 (Suppl.G) 77-83, 1989.

    Google Scholar 

  23. Thadani U., S.F. Hamilton, E. Olson, J.L. Anderson, R. Prasad, W. Voyles, R. Doyle, E. Kirsten, and M. Teague. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris. Am. J. Cardiol. 59, 756–762, 1987.

    Article  PubMed  CAS  Google Scholar 

  24. Thadani U., and P.J. de Vane. Efficacy of isosorbide mononitrate in angina pectoris. Amer. J. Cardiol. 70:67G–71G, 1992.

    Article  PubMed  CAS  Google Scholar 

  25. Tzivioni, D., S. Gottlieb, N.S. Khurmi, A. Medina, A. Gavish, and S. Stern. Effect of Benazepril on myocardial ischemia in patients with chronic stable angina pectoris. Eur. Heart J. 13:1129–1134, 1992.

    Google Scholar 

  26. Unger P., A. Leone, M Staroukine, S. Degre, and G. Berkenboom. Hemodynamic response to molsidomine in patients with ischemic cardiomyopathy tolerant to isosorbide dinitrate. J. Cardiovasc. Pharmacol 18:888–894, 1991.

    Article  PubMed  CAS  Google Scholar 

  27. Winter U.J., M. Böhm, and E. Erdmann. Überlegungen zum möglichen Stellenwert der neuen Ca2-An-tagonisten bei der Herzinsuffizienztherapie. Herz/Kreislauf 27:162–167.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Sport- und Leistungsmedizin University of Ulm, Ulm, D-89070, Germany

    Martin Stauch

Authors
  1. Martin Stauch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Ulm, Ulm, Germany

    Jürgen M. Steinacker

  2. South Bank University, London, England

    Susan A. Ward

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Stauch, M. (1996). Effects of Drugs on Exercise Tolerance in Patients with Cardiovascular Disease. In: Steinacker, J.M., Ward, S.A. (eds) The Physiology and Pathophysiology of Exercise Tolerance. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5887-3_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5887-3_41

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7700-9

  • Online ISBN: 978-1-4615-5887-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation